Neumora Therapeutics, Inc.

NasdaqGS:NMRA Stock Report

Market Cap: US$1.6b

Neumora Therapeutics Management

Management criteria checks 1/4

Neumora Therapeutics' CEO is Henry Gosebruch, appointed in Jul 2023, has a tenure of 1.33 years. total yearly compensation is $22.00M, comprised of 1.5% salary and 98.5% bonuses, including company stock and options. directly owns 0.32% of the company’s shares, worth $5.07M. The average tenure of the management team and the board of directors is 1.6 years and 3.9 years respectively.

Key information

Henry Gosebruch

Chief executive officer

US$22.0m

Total compensation

CEO salary percentage1.5%
CEO tenure1.3yrs
CEO ownership0.3%
Management average tenure1.6yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Neumora Therapeutics: A Story Of A Class II Biotech

Oct 16

We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Jun 18
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely

Neumora: Phase 3 MDD Readout In H2-24 Could Get Ball Rolling

Feb 08

CEO Compensation Analysis

How has Henry Gosebruch's remuneration changed compared to Neumora Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$294m

Jun 30 2024n/an/a

-US$274m

Mar 31 2024n/an/a

-US$254m

Dec 31 2023US$22mUS$338k

-US$236m

Compensation vs Market: Henry's total compensation ($USD22.00M) is above average for companies of similar size in the US market ($USD5.54M).

Compensation vs Earnings: Insufficient data to compare Henry's compensation with company performance.


CEO

Henry Gosebruch (51 yo)

1.3yrs

Tenure

US$21,999,269

Compensation

Mr. Henry O. Gosebruch serves as President, Chief Executive Officer and Director at Neumora Therapeutics, Inc. since July 2023. He serves as an Independent Director at Acelyrin, Inc. since March 17, 2023....


Leadership Team

NamePositionTenureCompensationOwnership
Paul Berns
Co-Founder & Executive Chairman4.8yrsUS$8.57m4.73%
$ 73.9m
Henry Gosebruch
President1.3yrsUS$22.00m0.32%
$ 5.1m
Jason Duncan
Chief Legal Officerless than a yearUS$4.41mno data
Robert Lenz
Head of Research & Development1.2yrsUS$13.58m0%
$ 0
Carol Suh
Co-Founder & COO1.8yrsno data0.18%
$ 2.8m
Robert Poole
Co-Founder & Advisorno datano datano data
Joshua Pinto
Chief Financial Officer3.4yrsUS$3.82m0.086%
$ 1.3m
Michael Milligan
Principal Accounting Officerno datano data0.0024%
$ 37.0k
Rajesh Manchanda
Chief Technical Operations Officer1.3yrsno datano data
Nicholas Brandon
Chief Scientific Officer2.8yrsno datano data
Amy Sullivan
Chief Human Resources Officer2.2yrsno datano data
John V. Reynders
Chief Data Sciences Advisorno datano datano data

1.6yrs

Average Tenure

51yo

Average Age

Experienced Management: NMRA's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Paul Berns
Co-Founder & Executive Chairman4.8yrsUS$8.57m4.73%
$ 73.9m
Henry Gosebruch
President1.3yrsUS$22.00m0.32%
$ 5.1m
Matthew Fust
Independent Director3.9yrsUS$485.53k0.012%
$ 194.3k
Edward Roberts
Member of Scientific Advisory Boardno datano datano data
Kristina Burow
Independent Director4.8yrsUS$686.60k0.017%
$ 267.0k
Mark Daly
Member of Scientific Advisory Boardno datano datano data
Gaurav Singal
Member of Technology Advisory Boardno datano datano data
Alaa Halawa
Independent Director2.2yrsUS$671.20kno data
Sandeep Datta
Member of Scientific Advisory Boardno datano datano data
John Krystal
Member of Scientific Advisory Boardno datano datano data
Andrew Trister
Member of Technology Advisory Boardno datano datano data
Patrick Sullivan
Member of Scientific Advisory Boardno datano datano data

3.9yrs

Average Tenure

51yo

Average Age

Experienced Board: NMRA's board of directors are considered experienced (3.9 years average tenure).